StonvexLoading…
StonvexStonvexStonvexCore line items from LSH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $13.11M | $6.10M | $17.79M | $11.48M |
Operating Income | $-2.76M | $-1.27M | $-4.96M | $-4.40M |
Net Income | $-2.94M | $-1.36M | $-5.25M | $-4.35M |
EPS (Diluted) | $-0.17 | $-0.09 | $-0.69 | $-0.58 |
Total Assets | $24.30M | $18.64M | $14.41M | $9.94M |
Total Liabilities | $12.12M | $11.68M | $11.56M | $9.19M |
Cash & Equivalents | $1.64M | $4.54M | $4.96M | $1.50M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-2.70M | $-2.21M |
Shares Outstanding | 34.43M | 17.43M | 10.50M | 7.50M |